US Stocks
/
Gyre Therapeutics, Inc. Share Price

Gyre Therapeutics, Inc. Share Price

NASDAQ: GYRE | Small Cap
$7.08
+$0.32 (4.73%) Last updated on 10 Oct, 2026 | 00:33 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Gyre Therapeutics, Inc. Stock Performance

Open
$6.83
Prev. Close
$6.76
Circuit Range
N/A
Day Range
$6.83 - $7.09
Year Range
$5.46 - $9.36
Volume
3,121
Average Traded
$6.99

Gyre Therapeutics, Inc. Share Price Today

As of 10 October 2026, Gyre Therapeutics, Inc.'s share price is $7.08. The stock opened at $6.83, compared to its previous close of $6.76. During today's trading session, Gyre Therapeutics, Inc.'s share price traded between $6.83 and $7.09, with an average price of $6.96. Over the past 52 weeks, the stock has recorded a high of $9.36 and a low of $5.46. In terms of performance, Gyre Therapeutics, Inc.'s share price has declined by 7.45% over the last six months and is down 8.53% on a year-on-year basis.

Gyre Therapeutics, Inc. Share Price Chart

$6.83$7.09
L
Show Current Price
H

Gyre Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$632.56M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.17
Revenue (TTM)
$116.59B
Return On Equity (TTM)
-17.11%
Profit Margin
4.31%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-422.99%

Gyre Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$30.56$37.20$22.52$29.11
Net Profit$3.61-$1.72-$8.69-$11.66
Net Profit Margin11.81%-4.62%-38.59%-40.05%
Income ChangeN/A-147.65%-405.23%-34.18%

Gyre Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$113.45$105.76$116.59
Net Profit-$92.93$12.09$5.03
Net Profit Margin-81.91%11.43%4.31%
Income ChangeN/A113.01%-58.40%

About Gyre Therapeutics, Inc.

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Gyre Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$7.31
$7.08
-3.68%
Sep 2026
$6.40
$7.34
+9.63%
Aug 2026
$5.93
$6.70
+16.42%
Jul 2026
$6.52
$5.75
-12.54%
Jun 2026
$5.92
$6.58
+11.62%
May 2026
$7.80
$5.89
-22.94%
Apr 2026
$7.19
$7.65
+9.91%
Mar 2026
$8.21
$6.96
-15.64%
Feb 2026
$8.00
$8.25
+1.85%
Jan 2026
$6.93
$8.10
+15.06%
Dec 2025
$7.77
$7.04
-8.81%
Nov 2025
$7.33
$7.72
-0.26%

GYRE Share Price FAQs

What is Gyre Therapeutics, Inc. share price today?

chevron-up
Gyre Therapeutics, Inc. share price today is $7.08 as on October 10, 2026 at 12:33 am IST.

What is the 52 week high and 52 week low of Gyre Therapeutics, Inc. stock?

chevron-up
The 52 week high of Gyre Therapeutics, Inc. stock is $9.36, while the 52 week low is $5.46 as of 10 Oct '26.

What is GYRE's market capitalisation today?

chevron-up
GYRE market capitalisation is $632.56M as of October 10, 2026, at 12:42 am IST.

What is GYRE's net income for the last quarter?

chevron-up
GYRE's net income for the last quarter is -11.66B USD.

What is the 5 year returns of GYRE?

chevron-up
The 5 year returns of GYRE is -85.65% as on 10 Oct '26.

What is the high & low stock price of GYRE today?

chevron-up
GYRE stock price hit a high of $7.09 and low of $6.83 as of 10 Oct '26.

Can I buy GYRE shares in India?

chevron-up
Yes. You can buy GYRE in India by opening an international trading account.